TSX News -
Medicenna Announces Upcoming Presentations at The Promise of Interleukin-2 Therapy Conference
TORONTO and HOUSTON, Aug. 27, 2024 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQB: MDNAF), a clinical-stage […]